Skip to content

CORPOSYS: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

CORPOSYS

BE 0515.962.301
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€366
2024 · €376-€10
Equity
€20,021
2024 · €21,378-€1,356
Cash
€14,451
2024 · €19,073-€4,621
Balance sheet total
€23,446
2024 · €23,986-€541

Largest movements

2024 to 2025
Assets
  • Cash -€4,621

    down €4,621 (-24.2%), from €19,073 to €14,451

    mainly Receivables within one year (-€4,079) and Contributions, distributions and other (-€1,722)

  • Receivables within one year +€4,079

    up €4,079 (+87.1%), from €4,682 to €8,760

    of which Trade receivables: +€4,235

Equity and liabilities
  • Reserves -€1,356

    down €1,356 (-39.5%), from €3,434 to €2,078

  • Other debts +€743

    up €743 (+50.0%), from €1,487 to €2,230

Income statement
  • Financial charges +€16

    up €16 (+6.1%), from €271 to €287

  • Other operating charges +€15

    up €15 (+2.5%), from €604 to €619

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €376
Gross operating margin +€13
Other operating charges -€15
Financial charges -€16
Taxes +€9
Result 2025 €366

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€2,899
Investment €0
Financing -€1,722
Cash 2024 €19,073
Net result for the year +€366
Receivables within one year -€4,079
Smaller working-capital items -€3
Trade debts +€74
Other debts +€743
Contributions, distributions and other -€1,722
Cash 2025 €14,451
Every line side by side 29 lines
Line Code 2024 2025 Change %
Total assets 20/58 €23,986 €23,446 -€541 -2.3%
Current assets 29/58 €23,986 €23,446 -€541 -2.3%
Amounts receivable within one year 40/41 €4,682 €8,760 +€4,079 +87.1%
Trade receivables 40 €4,235 €8,470 +€4,235 +100.0%
Other amounts receivable 41 €447 €290 -€156 -35.0%
Cash at bank and in hand 54/58 €19,073 €14,451 -€4,621 -24.2%
Deferred charges and accrued income 490/1 €232 €234 +€2 +0.9%
Total equity and liabilities 10/49 €23,986 €23,446 -€541 -2.3%
Equity 10/15 €21,378 €20,021 -€1,356 -6.3%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €3,434 €2,078 -€1,356 -39.5%
Distributable reserves 133 €3,434 €2,078 -€1,356 -39.5%
Profit (loss) carried forward 14 €11,743 €11,743 = 0.0%
Amounts payable 17/49 €2,608 €3,424 +€816 +31.3%
Amounts payable within one year 42/48 €2,608 €3,424 +€816 +31.3%
Trade debts 44 €585 €659 +€74 +12.6%
Suppliers 440/4 €585 €659 +€74 +12.6%
Taxes, remuneration and social security 45 €536 €535 -€1 -0.2%
Taxes 450/3 €536 €535 -€1 -0.2%
Other amounts payable 47/48 €1,487 €2,230 +€743 +50.0%
Other operating charges 640/8 €604 €619 +€15 +2.5%
Gross operating margin 9900 €1,443 €1,456 +€13 +0.9%
Operating profit (loss) 9901 €839 €836 -€3 -0.3%
Financial charges 65/66B €271 €287 +€16 +6.1%
Recurring financial charges 65 €271 €287 +€16 +6.1%
Profit (loss) for the period before taxes 9903 €568 €549 -€19 -3.3%
Income taxes 67/77 €192 €183 -€9 -4.8%
Profit (loss) for the period 9904 €376 €366 -€10 -2.6%
Profit (loss) for the period to be appropriated 9905 €376 €366 -€10 -2.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.